Rise Nano Optics (RNOLF) will sponsor INVISION MATCH! 2026, an optometry industry event running September 30 through October 2 in Las Vegas.
Rise plans to use pre-scheduled, one-on-one meetings to introduce SpectraGuard to independent practice owners as it expands U.S. commercialization. The lens treatment is designed to filter 100% of ultraviolet light and up to 90% of wavelengths between 400 and 600 nm. More than 20 private-practice optometry owners generating more than $1 million in annual revenue are expected to attend. Rise is developing a network of authorized optical laboratories capable of producing SpectraGuard lenses.
Rise Nano Optics (RNOLF) will attend The Vision Council's 2026 Lab Leadership Forum from September 16-18, 2026, at the M Resort Spa Casino in Henderson, Nevada, as part of its lab-first commercialization strategy for SpectraGuard™ lens technology.
The sold-out forum gathers leaders from the independent optical laboratory sector for discussions on equipment, lens design, lab management, and regulatory updates, alongside networking opportunities. Rise will be represented by Chief Commercial Officer Erik Ritchie and aims to engage decision-makers to integrate its patented SpectraGuard nanoparticle lens treatment, which is designed to filter 100% of UV light and up to 90% of 400-600 nm wavelengths, into existing lab manufacturing and distribution networks. Rise joined The Vision Council in August 2026 to expand industry relationships and market access.
Rise Nano Optics (CSE: EYE, OTCQB: RNOLF, FSE: U9Y) has joined The Vision Council, a major North American optical trade association representing hundreds of manufacturers, labs, retailers and technology companies. Membership provides access to market intelligence, standards work, government affairs initiatives, education and networking.
According to the company, this is a strategic step in commercializing its FDA Class I registered SPECTRAGUARD™ nano-optic lens technology, which is designed to filter up to 90% of high-energy visible light between 400 and 600 nanometers while preserving natural colour perception and clarity. Rise management will attend The Vision Council’s 2026 Lab Leadership Forum in Las Vegas. The company also reported that Nancy Goertzen resigned from its Board of Directors and related committees effective August 19, 2026.
Rise Nano Optics (CSE: EYE, OTCQB: RNOLF, FSE: U9Y) announced that its common shares are now listed and trading on the Frankfurt Stock Exchange under the symbol “U9Y”, a move aimed at broadening access to European institutional and retail investors and enhancing international capital markets visibility.
The company, which is commercializing its patented SPECTRAGUARD™ nano‑particle lens technology targeting blue light and high‑energy visible light between 400–600 nm, recently began a U.S. commercialization strategy and is pursuing a multi‑channel go‑to‑market approach. To support its European outreach, Rise engaged Dr. Reuter Investor Relations, an arm’s‑length Frankfurt-based IR and financial PR firm, for a six‑month term starting August 15, 2026 at a cash fee of €6,000 per month, with no securities granted. The mandate includes news translation and distribution, media and investor communications, social media support, and performance reporting focused on European capital markets.
Rise Nano Optics (CSE:EYE, OTCQB:RNOLF) reported that all resolutions were approved at its annual general and special meeting of shareholders held on August 5, 2026, at 10:00 a.m. Pacific Time. A total of 16,027,785 common shares, representing 39.35% of outstanding shares as of the record date, were represented.
Shareholders set the number of directors at five and elected all nominees. Four directors each received 16,027,785 votes for (100.00%). Director Nancy Goertzen received 1,137,048 votes for (7.09%) and 14,890,737 withheld (92.91%).
Shareholders also approved the appointment of Ziv Haft Certified Public Accountants (Israel), a BDO Member Firm, as auditors, the Company’s equity incentive plan, the continuation of the Company from the Business Corporations Act (British Columbia) to the Business Corporations Act (Ontario), and the repeal of all existing bylaws with the enactment of new By-Law No. 1. Each of these resolutions received 16,027,785 votes for (100%) and zero withheld.
Rise Nano Optics (OTCQB: RNOLF, CSE: EYE) announced its common shares have commenced trading on the OTCQB Venture Market and are now DTC eligible as of August 4, 2026. The company aims to broaden U.S. investor access, improve trading efficiency and support its U.S. capital markets strategy.